Atlas Trials

Botulinum Toxin in Raynaud's Phenomenon

Clinical trial NCT05125029 · COMPLETED

Trial details

NCT number
NCT05125029
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Raynaud Phenomenon
Start date
2022-02-10
Primary completion
2025-05-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.